ITZ-1 is a selective inhibitor of the extracellular signal-regulated kinase (ERK) in the mitogen-activated protein kinase (MAPK) pathway, exhibiting an IC50 of 0.51 μM against interleukin-1β (IL-1β)-induced matrix metalloproteinase-13 (MMP-13) production. This compound effectively reduces MMP-13 expression and mitigates nitric oxide (NO)-induced chondrocyte apoptosis. ITZ-1 holds potential for advancing research in osteoarticular diseases.
ITZ-1 is a selective inhibitor of the extracellular signal-regulated kinase (ERK) in the mitogen-activated protein kinase (MAPK) pathway, exhibiting an IC50 of 0.51 μM against interleukin-1β (IL-1β)-induced matrix metalloproteinase-13 (MMP-13) production. This compound effectively reduces MMP-13 expression and mitigates nitric oxide (NO)-induced chondrocyte apoptosis. ITZ-1 holds potential for advancing research in osteoarticular diseases.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
